ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.
Niamh Coleman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.